Announcements Trials
Browse Landscape

Phase

Phase 4 1Phase 1/2 1Phase 1 1

Status

Completed 3

Sponsor Class

OTHER 3

Study Type

Observational 3Interventional 3

Sponsor

Cancer Type

Breast 5Other hematologic neoplasm 3Lymphoid 3Sarcoma 1Plasma cell 1Gastrointestinal 1

Conditions

Lymphoma 2571Precursor Cell Lymphoblastic Leukemia-Lymphoma 2086Lymphoma, Non-Hodgkin 2058Leukemia, Lymphocytic, Chronic, B-Cell 1771Lymphoma, Follicular 1652Lymphoma, Large B-Cell, Diffuse 1597Leukemia 1172Hodgkin Disease 1128Lymphoma, Mantle-Cell 1110Burkitt Lymphoma 887Leukemia, Myeloid, Acute 885Lymphoma, B-Cell, Marginal Zone 788Recurrence 779Multiple Myeloma 744Lymphoma, B-Cell 704Myelodysplastic Syndromes 615Neoplasms 494Lymphoma, T-Cell, Cutaneous 479Waldenstrom Macroglobulinemia 470Lymphoma, Large-Cell, Immunoblastic 456Mycosis Fungoides 383Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 382Lymphoma, Large-Cell, Anaplastic 362Sezary Syndrome 321Lymphoma, T-Cell, Peripheral 321Leukemia, Myelogenous, Chronic, BCR-ABL Positive 307Hematologic Neoplasms 299Myeloproliferative Disorders 288Neoplasms, Plasma Cell 270Blast Crisis 261

Interventions

Valsartan 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Interventional × Cardiomyopathies × Lymphoid × Clear all
NCT04737265 2025-07-03

NTproBNP-Guide

Abramson Cancer Center at Penn Medicine

Phase 1/2 Completed
101 enrolled
BreastLymphoid

Breast Neoplasms, Heart Failure, Lymphoma, Cardiomyopathies, Cardiotoxicity

NCT02509156 2020-11-05

SENECA

The University of Texas Health Science Center, Houston

Phase 1 Completed
46 enrolled 46 charts
BreastLymphoidOther hematologic neoplasmSarcoma

Breast Neoplasms, Leukemia, Lymphoma, Cardiomyopathies, Sarcoma

NCT00162955 2012-05-08

Prevention of CHOP-induced Chronic Cardiotoxicity

Osaka City University

Phase 4 Completed
150 enrolled
Lymphoid

Lymphoma, Non-Hodgkin, Cardiomyopathies

Data powered by HemOnc (CC BY 4.0) Colophon âš¡